申请人:Hoffman-La Roche Inc.
公开号:US05006651A1
公开(公告)日:1991-04-09
The invention relates compounds of the formula ##STR1## wherein R.sup.1 -R.sup.5 and X have the significance given in the description, and their pharmaceutically acceptable salts. The compounds of formula I inhibit the enzyme collagenase and can be used in the form of medicaments for the control or prevention of degenerative joint diseases such as rheumatoid arthritis and osteoarthritis.
本发明涉及公式## STR1 ##的化合物,其中R.sup.1-R.sup.5和X具有说明书中给出的含义,以及其药学上可接受的盐。公式I的化合物抑制胶原酶酶,并可用作药物的形式,用于控制或预防退行性关节疾病,如类风湿性关节炎和骨关节炎。